These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20363765)

  • 1. The fate of incomplete stent apposition with drug-eluting stents: an optical coherence tomography-based natural history study.
    Ozaki Y; Okumura M; Ismail TF; Naruse H; Hattori K; Kan S; Ishikawa M; Kawai T; Takagi Y; Ishii J; Prati F; Serruys PW
    Eur Heart J; 2010 Jun; 31(12):1470-6. PubMed ID: 20363765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late incomplete apposition after drug-eluting stent implantation: incidence and potential for adverse clinical outcomes.
    Siqueira DA; Abizaid AA; Costa Jde R; Feres F; Mattos LA; Staico R; Abizaid AA; Tanajura LF; Chaves A; Centemero M; Sousa AG; Sousa JE
    Eur Heart J; 2007 Jun; 28(11):1304-9. PubMed ID: 17478457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography.
    Gonzalo N; Barlis P; Serruys PW; Garcia-Garcia HM; Onuma Y; Ligthart J; Regar E
    JACC Cardiovasc Interv; 2009 May; 2(5):445-52. PubMed ID: 19463469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early vascular healing with biodegradable polymer coated sirolimus-eluting coronary stent implantation: assessed by optical coherence tomography results at 4-month follow-up.
    Abhyankar A; Prajapati J; Reddy S; Reddy S
    Minerva Cardioangiol; 2013 Jun; 61(3):313-22. PubMed ID: 23681134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography.
    Li S; Gai L; Yang T; Zhang L; Xu X; Bai Q; Xu H; Wang Y
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):768-75. PubMed ID: 22639418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of late incomplete stent apposition after sirolimus-eluting stent implantation on 4-year clinical events: intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS trials.
    Hoffmann R; Morice MC; Moses JW; Fitzgerald PJ; Mauri L; Breithardt G; Schofer J; Serruys PW; Stoll HP; Leon MB
    Heart; 2008 Mar; 94(3):322-8. PubMed ID: 17761505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute coronary syndrome is an independent risk factor for late incomplete stent apposition after sirolimus-eluting stent implantation.
    Zhang RY; DU R; Zhu ZB; Zhang Q; Hu J; Lü AK; Zhang JS; Shen WF
    Chin Med J (Engl); 2008 Dec; 121(24):2504-8. PubMed ID: 19187586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation.
    Cook S; Eshtehardi P; Kalesan B; Räber L; Wenaweser P; Togni M; Moschovitis A; Vogel R; Seiler C; Eberli FR; Lüscher T; Meier B; Jüni P; Windecker S
    Eur Heart J; 2012 Jun; 33(11):1334-43. PubMed ID: 22285579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study.
    Barlis P; Regar E; Serruys PW; Dimopoulos K; van der Giessen WJ; van Geuns RJ; Ferrante G; Wandel S; Windecker S; van Es GA; Eerdmans P; Jüni P; di Mario C
    Eur Heart J; 2010 Jan; 31(2):165-76. PubMed ID: 19889649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical coherence tomography findings in lesions after sirolimus-eluting stent implantation with peri-stent contrast staining.
    Tada T; Kadota K; Hosogi S; Kubo S; Ozaki M; Yoshino M; Miyake K; Eguchi H; Ohashi N; Hayakawa Y; Saito N; Otsuru S; Hasegawa D; Shigemoto Y; Habara S; Imai M; Tanaka H; Fuku Y; Oka N; Kato H; Yamamoto H; Fujii S; Goto T; Mitsudo K
    Circ Cardiovasc Interv; 2012 Oct; 5(5):649-56. PubMed ID: 23011265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms, pathophysiology, and clinical aspects of incomplete stent apposition.
    Attizzani GF; Capodanno D; Ohno Y; Tamburino C
    J Am Coll Cardiol; 2014 Apr; 63(14):1355-67. PubMed ID: 24530675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed coverage in malapposed and side-branch struts with respect to well-apposed struts in drug-eluting stents: in vivo assessment with optical coherence tomography.
    Gutiérrez-Chico JL; Regar E; Nüesch E; Okamura T; Wykrzykowska J; di Mario C; Windecker S; van Es GA; Gobbens P; Jüni P; Serruys PW
    Circulation; 2011 Aug; 124(5):612-23. PubMed ID: 21768536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial findings of impact of strut width on stent coverage and apposition of sirolimus-eluting stents assessed by optical coherence tomography.
    Nakatani S; Nishino M; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):776-81. PubMed ID: 22517601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of everolimus-eluting stent incomplete stent apposition: a serial optical coherence tomography analysis.
    Shimamura K; Kubo T; Akasaka T; Kozuma K; Kimura K; Kawamura M; Sumiyoshi T; Ino Y; Yoshiyama M; Sonoda S; Igarashi K; Miyazawa A; Uzui H; Sakanoue Y; Shinke T; Morino Y; Tanabe K; Kadota K; Kimura T
    Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):23-8. PubMed ID: 25342855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravascular ultrasound comparison of sirolimus-eluting stent versus bare metal stent implantation in diseased saphenous vein grafts (from the RRISC [Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent] trial).
    Agostoni P; Vermeersch P; Semeraro O; Verheye S; Van Langenhove G; Van den Heuvel P; Convens C; Van den Branden F; Bruining N
    Am J Cardiol; 2007 Jul; 100(1):52-8. PubMed ID: 17599440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worsening late-acquired incomplete stent apposition after sirolimus-eluting stent implantation for a chronic total occlusion lesion.
    Nakazato K; Misaka T; Sakamoto N; Kunii H; Saitoh S; Takeishi Y
    Cardiovasc Interv Ther; 2015 Jan; 30(1):85-91. PubMed ID: 24595874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neointimal coverage of sirolimus-eluting stents 6 months and 12 months after implantation: evaluation by optical coherence tomography.
    Yao ZH; Matsubara T; Inada T; Suzuki Y; Suzuki T
    Chin Med J (Engl); 2008 Mar; 121(6):503-7. PubMed ID: 18364133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography.
    Chen BX; Ma FY; Luo W; Ruan JH; Xie WL; Zhao XZ; Sun SH; Guo XM; Wang F; Tian T; Chu XW
    Heart; 2008 May; 94(5):566-70. PubMed ID: 17923466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very late thrombosis after subintimal sirolimus-eluting stent implantation during percutaneous coronary intervention for chronic total occlusion.
    Miyazaki S; Hiasa Y; Kishi K
    J Invasive Cardiol; 2010 Aug; 22(8):E162-5. PubMed ID: 20679685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.